Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Upper Limb Essential Tremor

NCT05216250 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05216250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05216250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Upper Limb Essential Tremor
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Completed
Start date
April 12, 2022
Completion date
February 3, 2025
Enrollment
174 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

upper limb essential tremor (ul et)